Peringatan Keamanan

The severity of adverse effects to a corticorelin injection appear to be dose-dependent. Dosages above 1 mcg/kg are not recommended. While few adverse effects have been observed at the 1 mcg/kg or 100 mcg dose, higher doses have been associated with transient tachycardia, decreased blood pressure, loss of consciousness, and asystole.

Corticorelin ovine triflutate

DB09067

biotech approved

Deskripsi

Corticorelin, available commercially as corticorelin ovine triflutate (tradename Acthrel), is a synthetic form of the peptide human corticotropin-releasing hormone (hCRH), a potent stimulator of adrenocorticotropic hormone (ACTH) release from the anterior pituitary. Endogenous forms hCRH are involved in the stress response and its main function is stimulation of the pituitary to release ACTH.

It is used as a diagnostic agent to evaluate the status of the pituitary-adrenal axis in the differentiation of a pituitary source from an ectopic source of excessive ACTH secretion. It provides a differential diagnosis for Cushing's disease (a pituitary source of ACTH excess) or of ectopic ACTH syndrome (an ectopic source of ACTH excess). If corticorelin injection results in an increase of plasma ACTH and cortisol, the patient is diagnosed with Cushing's disease. However, if corticorelin injection does not result in an increase of plasma ACTH and cortisol, the patient is diagnosed with ectopic ACTH syndrome.

Struktur Molekul 2D

Struktur tidak tersedia

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) Plasma half-lives for IR-corticorelin are 11.6 ± 1.5 minutes (mean ± SE) for the fast component and 73 ± 8 minutes for the slow component.
Volume Distribusi The mean volume of distribution for IR-corticorelin is 6.2 ± 0.5 L
Klirens (Clearance) 95 ± 11 L/m2/day

Absorpsi

Plasma ACTH levels in normal subjects increased 2 minutes after injection of corticorelin doses of ?0.3 mcg/kg and reached peak levels after 10-15 minutes. Plasma cortisol levels increased within 10 minutes and reached peak levels at 30 to 60 minutes.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

75 Data
Flunisolide The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Flunisolide.
Beclomethasone dipropionate The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Beclomethasone dipropionate.
Betamethasone The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Betamethasone.
Fluticasone propionate The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Fluticasone propionate.
Fluocinolone acetonide The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Fluocinolone acetonide.
Triamcinolone The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Triamcinolone.
Prednisone The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Prednisone.
Fludrocortisone The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Fludrocortisone.
Hydrocortisone The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Hydrocortisone.
Prednisolone The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Prednisolone.
Methylprednisolone The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Methylprednisolone.
Trilostane The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Trilostane.
Budesonide The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Budesonide.
Dexamethasone The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Dexamethasone.
Corticotropin The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Corticotropin.
Cortisone acetate The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Cortisone acetate.
Paramethasone The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Paramethasone.
Ciclesonide The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Ciclesonide.
Aldosterone The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Aldosterone.
Fluticasone furoate The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Fluticasone furoate.
Fluprednidene The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Fluprednidene.
Tixocortol The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Tixocortol.
Fluprednisolone The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Fluprednisolone.
Meprednisone The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Meprednisone.
Dexamethasone isonicotinate The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Dexamethasone isonicotinate.
Melengestrol The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Melengestrol.
Deflazacort The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Deflazacort.
Cortivazol The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Cortivazol.
Prednylidene The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Prednylidene.
Fluocortin The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Fluocortin.
Fluperolone The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Fluperolone.
Cloprednol The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Cloprednol.
Fluclorolone The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Fluclorolone.
Fluticasone The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Fluticasone.
Mometasone furoate The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Mometasone furoate.
Hydrocortisone acetate The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Hydrocortisone acetate.
Hydrocortisone cypionate The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Hydrocortisone cypionate.
Hydrocortisone succinate The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Hydrocortisone succinate.
Prednisolone phosphate The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Prednisolone phosphate.
Prednisolone hemisuccinate The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Prednisolone hemisuccinate.
Methylprednisolone hemisuccinate The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Methylprednisolone hemisuccinate.
Prednisone acetate The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Prednisone acetate.
Clocortolone acetate The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Clocortolone acetate.
Melengestrol acetate The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Melengestrol acetate.
Betamethasone phosphate The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Betamethasone phosphate.
Cortisone The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Cortisone.
Clobetasol propionate The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Clobetasol propionate.
Fluocinonide The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Fluocinonide.
Hydrocortisone butyrate The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Hydrocortisone butyrate.
Desoximetasone The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Desoximetasone.
Mometasone The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Mometasone.
Fluocortolone The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Fluocortolone.
Prednisolone acetate The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Prednisolone acetate.
Fluorometholone The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Fluorometholone.
Difluocortolone The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Difluocortolone.
Flumethasone The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Flumethasone.
Methylprednisolone aceponate The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Methylprednisolone aceponate.
Ardeparin The risk or severity of hypotension and sinus node depression can be increased when Ardeparin is combined with Corticorelin ovine triflutate.
Heparin The risk or severity of hypotension and sinus node depression can be increased when Heparin is combined with Corticorelin ovine triflutate.
Enoxaparin The risk or severity of hypotension and sinus node depression can be increased when Enoxaparin is combined with Corticorelin ovine triflutate.
Sulodexide The risk or severity of hypotension and sinus node depression can be increased when Sulodexide is combined with Corticorelin ovine triflutate.
Semuloparin The risk or severity of hypotension and sinus node depression can be increased when Semuloparin is combined with Corticorelin ovine triflutate.
Danaparoid The risk or severity of hypotension and sinus node depression can be increased when Danaparoid is combined with Corticorelin ovine triflutate.
Dalteparin The risk or severity of hypotension and sinus node depression can be increased when Dalteparin is combined with Corticorelin ovine triflutate.
Tinzaparin The risk or severity of hypotension and sinus node depression can be increased when Tinzaparin is combined with Corticorelin ovine triflutate.
Nadroparin The risk or severity of hypotension and sinus node depression can be increased when Nadroparin is combined with Corticorelin ovine triflutate.
Bemiparin The risk or severity of hypotension and sinus node depression can be increased when Bemiparin is combined with Corticorelin ovine triflutate.
Parnaparin The risk or severity of hypotension and sinus node depression can be increased when Parnaparin is combined with Corticorelin ovine triflutate.
Reviparin The risk or severity of hypotension and sinus node depression can be increased when Reviparin is combined with Corticorelin ovine triflutate.
Dexamethasone acetate The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Dexamethasone acetate.
Corticotropin zinc hydroxide The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Corticotropin zinc hydroxide.
Fluocortolone pivalate The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Fluocortolone pivalate.
Fluocortolone caproate The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Fluocortolone caproate.
Desoxycortone The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Desoxycortone.
Vamorolone The therapeutic efficacy of Corticorelin ovine triflutate can be decreased when used in combination with Vamorolone.

Target Protein

Corticotropin-releasing factor receptor 1 CRHR1
Corticotropin-releasing factor receptor 2 CRHR2

Referensi & Sumber

Belum ada data referensi/link/attachment untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field referensi.

Contoh Produk & Brand

Produk: 1 • International brands: 0
Produk
  • Acthrel
    Injection, powder, lyophilized, for solution • 100 ug/2mL • Intravenous • US • Approved

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul